Sort
82,697 grants matching “vaccine development”
Immune signatures of vaccine responses in vulnerable populations
$2,706,289Ruth R Montgomery · Yale University · U19 · FY2023 · AI
Role of antigen-specific T cell responses in the control of TB
$2,704,904Henry M Blumberg · Emory University · U19 · FY2014 · AI
Technologies to Advance Next Generation Anthrax Vaccines
$2,704,724Vidadi Yusibov · Center For Expermental Software Engr Md · N01 · FY2017 · AI
China's Integrated Programs for Research on AIDS
$2,704,029National Center/Aids/Std Control/Prevent · U19 · FY2005 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$2,703,462Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2013 · AI
Structure-function analysis of infection- and vaccine-induced B-cell repertoires
$2,701,758Stephen C Harrison · Boston Children'S Hospital · P01 · FY2021 · AI
University of New Mexico Interdisciplinary HPV Prevention Center
$2,700,586Cosette Marie Wheeler · University Of New Mexico Health Scis Ctr · U19 · FY2010 · AI
DMID Clinical Trial Management
$2,700,366Fred Batzold · Ppd Development Lp · N01 · FY2010 · AI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$2,700,161Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Nonhuman primate scientific research support component
$2,700,027Norman L Letvin · Duke University · UM1 · FY2012 · AI
SPORE in Prostate Cancer
$2,699,757Sloan-Kettering Institute For Cancer Res · P50 · FY2001 · CA
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support and Concept and Protocol and Assay Development
$2,699,525Robert Frenck · Cincinnati Childrens Hosp Med Ctr · N01 · FY2019 · AI
SPORE IN BREAST CANCER
$2,699,321Johns Hopkins University · P50 · FY2000 · CA
Mucusal and Systemic Immunity, Vaccines and Microbiota Interplay in Humans
$2,696,170Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2015 · AI
Mucusal and Systemic Immunity, Vaccines and Microbiota Interplay in Humans
$2,696,170Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2017 · AI
Mucusal and Systemic Immunity, Vaccines and Microbiota Interplay in Humans
$2,696,170Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2018 · AI
Mucusal and Systemic Immunity, Vaccines and Microbiota Interplay in Humans
$2,696,170Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2016 · AI
Plasma Cells in Health and Disease
$2,695,938Ignacio E. Sanz · Emory University · P01 · FY2022 · AI
HIV/AIDS Vaccine Development
$2,695,631Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
South African Medical Research Council Clinical Trials Unit (MRC CTU)
$2,695,610Ameena Goga · Medical Research Council Of South Africa · UM1 · FY2020 · AI
Integrated Support Services
$2,694,914Joan Elizabeth Nichols · University Of Texas Med Br Galveston · UC7 · FY2015 · AI
SPORE in Prostate Cancer
$2,694,329Michael M. Ittmann · Baylor College Of Medicine · P50 · FY2006 · CA
Allogeneic Immunotherapy for cancer and nonmalignant hematological disorders
$2,693,826Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
KARABELO Clinical Trials Unit for NIAID Networks
$2,693,563Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2014 · AI
Isolation and Deep Sequencing of Monoclonal Antibodies Against HIV
$2,692,904John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI